WeightWatchers Plans to Sell Novo Nordisk’s Wegovy Pill
WeightWatchers’ CEO stated on Wednesday it plans to promote Novo Nordisk’s much-anticipated Wegovy in tablet type whether it is launched …
Novo
Novo Nordisk Offers $9 Billion Unsolicited Bid for Obesity Drug Maker Metsera
Novo Nordisk has launched a shock $9bn (£6.9bn) supply for the US obesity-focused biotech agency Metsera that might gazump an …
Innovent Biologics Challenges Novo and Lilly in China’s GLP-1 Market
Xinermei, launched in July, is the third once-weekly injectable GLP-1 weight administration remedy obtainable in China after Novo Nordisk’s Wegovy …
Novo Nordisk Reports Positive Test Results For GLP-1 Pill
The worth of the drugmaker Novo Nordisk jumped by about £9bn on Thursday after analysis confirmed that taking its new …